These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15002381)

  • 1. One more rheumatoid drug.
    Health News; 2004 Jan; 10(1):8. PubMed ID: 15002381
    [No Abstract]   [Full Text] [Related]  

  • 2. Orencia approved for rheumatoid arthritis.
    Health News; 2006 Mar; 12(3):2. PubMed ID: 16535763
    [No Abstract]   [Full Text] [Related]  

  • 3. A signal achievement in the treatment of arthritis.
    Cron RQ
    Arthritis Rheum; 2005 Aug; 52(8):2229-32. PubMed ID: 16052533
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell agents in the treatment of rheumatoid arthritis - 2011 update.
    Solomon GE
    Bull NYU Hosp Jt Dis; 2011; 69(3):230-2. PubMed ID: 22035434
    [No Abstract]   [Full Text] [Related]  

  • 5. T-cell agents in the treatment of rheumatoid arthritis - 2012 update.
    Solomon GE
    Bull NYU Hosp Jt Dis; 2012; 70(3):191-4. PubMed ID: 23259627
    [No Abstract]   [Full Text] [Related]  

  • 6. Abatacept helps people with severe RA.
    Health News; 2006 Oct; 12(10):2. PubMed ID: 17165175
    [No Abstract]   [Full Text] [Related]  

  • 7. Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis.
    Amezcua-Guerra LM; Hernández-Martínez B; Pineda C; Bojalil R
    Gut; 2006 Jul; 55(7):1059-60. PubMed ID: 16766771
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab and abatacept for rheumatoid arthritis.
    BMJ Group
    Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abatacept in the treatment of active rheumatoid arthritis].
    Nielsen H; Hansen A
    Ugeskr Laeger; 2009 Jan; 171(4):214-7. PubMed ID: 19174034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abatacept therapy for rheumatoid arthritis in the setting of hepatitis C infection.
    Mahajan TD; Hooker R; Maher L; Brown G; Reimold A
    J Clin Rheumatol; 2010 Oct; 16(7):332-4. PubMed ID: 20859223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept].
    Castañeda S; Martínez Calatrava MJ; Herrero-Beaumont G
    Rev Clin Esp; 2012 May; 212(5):244-54. PubMed ID: 22176928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
    Konsta M; Rallis E; Karameris A; Stratigos A; Sfikakis PP; Iliopoulos A
    J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):257-8. PubMed ID: 22280512
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte-associated antigen 4 Ig-induced asthma in the treatment of rheumatoid arthritis.
    Bao J; Li T; Zhao J; Zhang CY
    J Rheumatol; 2012 Sep; 39(9):1903. PubMed ID: 22942310
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
    MMW Fortschr Med; 2008 Jun; 150(26-27):56-7. PubMed ID: 18683309
    [No Abstract]   [Full Text] [Related]  

  • 15. Is abatacept an effective treatment for patients with RA who do not respond to other anti-TNF treatments?
    Taylor PC
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):128-9. PubMed ID: 16932670
    [No Abstract]   [Full Text] [Related]  

  • 16. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis.
    Brasington R
    J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic T-lymphocyte antigen 4-immunoglobulin in rheumatoid arthritis.
    Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):381-91, viii. PubMed ID: 15172047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nursing guide to infusion therapy with abatacept for the treatment of rheumatoid arthritis.
    Barr C
    J Infus Nurs; 2007; 30(2):96-104; quiz 120. PubMed ID: 17413494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-class biologic to enter rheumatoid arthritis fray.
    Garber K
    Nat Biotechnol; 2005 Nov; 23(11):1323-4. PubMed ID: 16273043
    [No Abstract]   [Full Text] [Related]  

  • 20. Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
    Scheinfeld N
    J Dermatolog Treat; 2006; 17(4):229-34. PubMed ID: 16971318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.